Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

about

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

Item

http://www.wikidata.org/entity/Q42659935

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

@en

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

@nl

type

Item

label

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

@en

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

@nl

prefLabel

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

@en

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

@nl

P1476

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.

@en

P2093

Chao Li

http://www.w3.org/2001/XMLSchema#string

Chunhua Dong

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

HE4 as a biomarker for ovarian and endometrial cancer management.

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.

The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.

Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome.

P304

1013-1017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12669/PJMS.334.12755

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29067084

http://www.w3.org/2001/XMLSchema#string

P932

5648931

http://www.w3.org/2001/XMLSchema#string